Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1993 1
2000 1
2003 1
2004 1
2006 3
2007 3
2008 1
2009 2
2010 4
2011 2
2012 1
2013 2
2014 3
2015 2
2016 3
2017 1
2018 2
2019 2
2020 3
2021 3
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Early progressive calcific cardiac valvular disease"
Page 1
Calcification of the heart: mechanisms and therapeutic avenues.
Shekar C, Budoff M. Shekar C, et al. Expert Rev Cardiovasc Ther. 2018 Jul;16(7):527-536. doi: 10.1080/14779072.2018.1484282. Epub 2018 Jun 12. Expert Rev Cardiovasc Ther. 2018. PMID: 29860888 Free PMC article. Review.
Newer therapies have shown to lower progression of coronary calcification, thus being beneficial in slowing progression of atherosclerotic disease. As British Epidemiologist Geoffrey Rose states, the best predictor of a life-threatening disea …
Newer therapies have shown to lower progression of coronary calcification, thus being beneficial in slowing progression …
(18)F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases.
De Azevedo D, Geers J, Gheysens O, Dweck M, Vancraeynest D. De Azevedo D, et al. Semin Nucl Med. 2023 Mar;53(2):241-257. doi: 10.1053/j.semnuclmed.2022.08.007. Epub 2022 Sep 16. Semin Nucl Med. 2023. PMID: 36116988 Review.
Valve degeneration and atherosclerosis are mediated by inflammation and calcification and inevitably progress over time. ...Molecular imaging has the ability to provide complementary information related to disease activity, which may allow us to detect …
Valve degeneration and atherosclerosis are mediated by inflammation and calcification and inevitably progress over time …
Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links.
Mazzone A, Venneri L, Berti S. Mazzone A, et al. J Cardiovasc Med (Hagerstown). 2007 Dec;8(12):983-9. doi: 10.2459/JCM.0b013e32802e6c3d. J Cardiovasc Med (Hagerstown). 2007. PMID: 18163008 Review.
Aortic valve stenosis (AVS), including a range of disorder severities, from mild leaflet thickening without valve obstruction, 'aortic sclerosis', to severe calcific aortic stenosis, is a progressive, active process of valve modification, mediat …
Aortic valve stenosis (AVS), including a range of disorder severities, from mild leaflet thickening without valve obstruction, …
Pathophysiology, emerging techniques for the assessment and novel treatment of aortic stenosis.
Shah SM, Shah J, Lakey SM, Garg P, Ripley DP. Shah SM, et al. Open Heart. 2023 Mar;10(1):e002244. doi: 10.1136/openhrt-2022-002244. Open Heart. 2023. PMID: 36963766 Free PMC article. Review.
Evolving from the traditional thought of a passive degenerative disease, developing a greater understanding of the condition's mechanistic underpinning has shifted the paradigm to an active disease process. ...Novel approaches are developing to address this through: …
Evolving from the traditional thought of a passive degenerative disease, developing a greater understanding of the condition's mechan …
Bicuspid aortic valve outcomes.
Rodrigues I, Agapito AF, de Sousa L, Oliveira JA, Branco LM, Galrinho A, Abreu J, Timóteo AT, Rosa SA, Ferreira RC. Rodrigues I, et al. Cardiol Young. 2017 Apr;27(3):518-529. doi: 10.1017/S1047951116002560. Epub 2016 Dec 12. Cardiol Young. 2017. PMID: 27938448
OBJECTIVE: The aim of this study was to assess the incidence and predictors of cardiac events in adults with bicuspid aortic valve. METHODS: We carried out a retrospective analysis of cardiac outcomes in ambulatory adults with bicuspid aortic valve …
OBJECTIVE: The aim of this study was to assess the incidence and predictors of cardiac events in adults with bicuspid aortic …
Lp(a) in the Pathogenesis of Aortic Stenosis and Approach to Therapy with Antisense Oligonucleotides or Short Interfering RNA.
Di Costanzo A, Indolfi C, Franzone A, Esposito G, Spaccarotella CAM. Di Costanzo A, et al. Int J Mol Sci. 2023 Oct 6;24(19):14939. doi: 10.3390/ijms241914939. Int J Mol Sci. 2023. PMID: 37834387 Free PMC article. Review.
Several drugs have been tested to reduce low-density lipoprotein (LDL) and lipoprotein(a) (Lp(a)) levels, inflammation, and calcification. The Proprotein Convertase Subtilisin/Kexin type 9 inhibitors (PCSK9-i) could decrease the progression of aortic stenosis and th …
Several drugs have been tested to reduce low-density lipoprotein (LDL) and lipoprotein(a) (Lp(a)) levels, inflammation, and calcification …
The role of stress concentration in calcified bicuspid aortic valve.
Qin T, Caballero A, Mao W, Barrett B, Kamioka N, Lerakis S, Sun W. Qin T, et al. J R Soc Interface. 2020 Jun;17(167):20190893. doi: 10.1098/rsif.2019.0893. Epub 2020 Jun 10. J R Soc Interface. 2020. PMID: 32517630 Free PMC article.
Calcific aortic valve disease (CAVD) is the most common valvular heart disease in the aging population, and is now believed to be a slow, progressive, yet actively regulated process. The disease progression can be div …
Calcific aortic valve disease (CAVD) is the most common valvular heart disease in the aging popula …
Aortic stenosis: new pathophysiological mechanisms and their therapeutic implications.
Dimitrow PP. Dimitrow PP. Pol Arch Med Wewn. 2014;124(12):723-30. doi: 10.20452/pamw.2562. Pol Arch Med Wewn. 2014. PMID: 25563623 Free article. Review.
Aortic stenosis (AS) represents the most common type of acquired valvular heart disease. Its incidence increases with age; therefore, from 3% to 9% of adults over 75 years of age develop AS. The pathophysiological mechanisms and role of biomarkers in the p …
Aortic stenosis (AS) represents the most common type of acquired valvular heart disease. Its incidence increases with a …
Calcification and extracellular matrix dysregulation in human postmortem and surgical aortic valves.
Gomez-Stallons MV, Tretter JT, Hassel K, Gonzalez-Ramos O, Amofa D, Ollberding NJ, Mazur W, Choo JK, Smith JM, Kereiakes DJ, Yutzey KE. Gomez-Stallons MV, et al. Heart. 2019 Nov;105(21):1616-1621. doi: 10.1136/heartjnl-2019-314879. Epub 2019 Jun 5. Heart. 2019. PMID: 31171628
OBJECTIVES: Calcific aortic valve disease (CAVD) is a progressive disease ranging from aortic valve (AoV) sclerosis to AoV stenosis (AS), characterised by severe calcification with impaired leaflet function. Due to the lack of e …
OBJECTIVES: Calcific aortic valve disease (CAVD) is a progressive disease ranging from aortic valve …
Lipoprotein(a) is robustly associated with aortic valve calcium.
Kaiser Y, Singh SS, Zheng KH, Verbeek R, Kavousi M, Pinto SJ, Vernooij MW, Sijbrands EJG, Boekholdt SM, de Rijke YB, Stroes ESG, Bos D. Kaiser Y, et al. Heart. 2021 Sep;107(17):1422-1428. doi: 10.1136/heartjnl-2021-319044. Epub 2021 May 7. Heart. 2021. PMID: 33963048 Free PMC article.
In the Rotterdam Study cohort, higher Lp(a) concentrations were also associated with increase in aortic valve Agatston score (beta 0.19, 95% CI 0.06 to 0.32 per 50 mg/dL increase). ...These results provide further rationale to assess the effect of Lp(a) lowering int …
In the Rotterdam Study cohort, higher Lp(a) concentrations were also associated with increase in aortic valve Agatston score ( …
40 results